China is gaining a solid reputation as a pharmaceutical innovation hub, shifting from a copycat drug maker to one whose…
Read More »Sino Biopharmaceutical
In the summer of 2015, a time when China’s pharmaceutical market was in a phase of rapid expansion, a sudden…
Read More »
Jiangsu Hengrui Pharmaceuticals, a leading Chinese developer of novel drugs that recently received approval to go public in Hong Kong,…
Read More »
An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced…
Read More »